المؤلفون: Nishiyama M; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Takeda S; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Watanabe Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Iida M; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Yamamoto T; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Nakashima C; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Matsui H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Shindo Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Tokumitsu Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Tomochika S; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Ioka T; Oncology Center, Yamaguchi University Hospital, Ube, Japan., Nagano H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan; hnagano@yamaguchi-u.ac.jp.

المصدر: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1790-1798.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

مواضيع طبية MeSH: Esophagectomy*/adverse effects , Esophagectomy*/methods , Esophageal Neoplasms*/surgery , Pneumonia*/prevention & control , Pneumonia*/etiology , Pneumonia*/epidemiology , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Postoperative Complications*/prevention & control , Postoperative Complications*/etiology, Humans ; Male ; Female ; Aged ; Middle Aged ; Anti-Bacterial Agents/therapeutic use ; Anti-Bacterial Agents/administration & dosage ; Retrospective Studies ; Risk Factors

المؤلفون: Pipkin T; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA., Pope S; Department of Pharmacy, Emory University Hospital Midtown, Atlanta, GA, USA., Killian A; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA., Green S; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA., Albrecht B; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA., Nugent K; Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, USA.; Division of Critical Care Medicine, Emory University School of Medicine, Atlanta, GA, USA.

المصدر: Journal of intensive care medicine [J Intensive Care Med] 2024 Sep; Vol. 39 (9), pp. 860-865. Date of Electronic Publication: 2024 Feb 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 8610344 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1489 (Electronic) Linking ISSN: 08850666 NLM ISO Abbreviation: J Intensive Care Med Subsets: MEDLINE

مواضيع طبية MeSH: Vancomycin*/adverse effects , Vancomycin*/administration & dosage , Acute Kidney Injury*/chemically induced , Piperacillin, Tazobactam Drug Combination*/adverse effects , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Critical Illness*/therapy , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/administration & dosage , Renal Insufficiency, Chronic*/complications , Drug Therapy, Combination*/adverse effects, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Hospital Mortality ; Intensive Care Units ; Length of Stay/statistics & numerical data ; Risk Factors ; Incidence

المؤلفون: Chanderraj R; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Medicine Service, Infectious Diseases Section, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan., Admon AJ; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor., He Y; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor., Nuppnau M; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor., Albin OR; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan., Prescott HC; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.; Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.; Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan., Dickson RP; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor., Sjoding MW; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.; Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor.

المصدر: JAMA internal medicine [JAMA Intern Med] 2024 Jul 01; Vol. 184 (7), pp. 769-777.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Cefepime*/administration & dosage , Cefepime*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/therapeutic use , Sepsis*/drug therapy , Sepsis*/mortality, Humans ; Male ; Female ; Retrospective Studies ; Aged ; Middle Aged

المؤلفون: Granholm A; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark., Munch MW; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark., Meier N; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark., Sjövall F; Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences, Lund University, Lund, Sweden., Helleberg M; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Hertz FB; Department of Clinical Microbiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark., Kaas-Hansen BS; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Thorsen-Meyer HC; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark., Andersen LW; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.; Prehospital Emergency Medical Services, Aarhus, Denmark., Rasmussen BS; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.; Department of Anaesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Andersen JS; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Albertsen TL; Sentinel Unit, Sundhed.dk, Odense, Denmark., Kjær MN; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark., Jensen AKG; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Lange T; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Perner A; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Møller MH; Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

المصدر: Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2024 Sep; Vol. 68 (8), pp. 1107-1119. Date of Electronic Publication: 2024 May 20.

نوع المنشور: Journal Article; Randomized Controlled Trial; Comparative Study; Clinical Trial Protocol

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0370270 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-6576 (Electronic) Linking ISSN: 00015172 NLM ISO Abbreviation: Acta Anaesthesiol Scand Subsets: MEDLINE

مواضيع طبية MeSH: Meropenem*/therapeutic use , Meropenem*/administration & dosage , Sepsis*/drug therapy , Sepsis*/mortality , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage, Humans ; Adult ; Critical Illness ; Male

المؤلفون: Dulhunty JM; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Redcliffe Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia., Brett SJ; Imperial College Healthcare NHS Trust, London, United Kingdom.; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., De Waele JJ; Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium., Rajbhandari D; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Billot L; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Cotta MO; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia., Davis JS; Infection Research Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, New South Wales, Australia.; Department of Infectious Diseases, John Hunter Hospital, Newcastle, New South Wales, Australia., Finfer S; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia.; School of Public Health, Imperial College London, United Kingdom., Hammond NE; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia.; Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, New South Wales, Australia., Knowles S; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Liu X; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., McGuinness S; Auckland City Hospital, Auckland, New Zealand.; Medical Research Institute of New Zealand, Wellington, New Zealand., Mysore J; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Paterson DL; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia.; Saw Swee Hock School of Public Health and Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Peake S; The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.; School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.; School of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Rhodes A; St George's University Hospitals NHS Foundation Trust, London, United Kingdom.; St George's University of London, London, United Kingdom., Roberts JA; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia.; Herston Infectious Diseases Institute, Metro North Health, Brisbane, Queensland, Australia.; Department of Anesthesiology, Critical Care, Pain, and Emergency Medicine, University Hospital of Nîmes, Nîmes, France., Roger C; Department of Anesthesiology, Critical Care, Pain, and Emergency Medicine, University Hospital of Nîmes, Nîmes, France.; University of Montpellier, Montpellier, France., Shirwadkar C; Blacktown Hospital, Sydney, New South Wales, Australia., Starr T; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Metro North Health, Brisbane, Queensland, Australia., Taylor C; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Myburgh JA; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia.; St George Hospital, Sydney, New South Wales, Australia., Lipman J; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia.; Department of Anesthesiology, Critical Care, Pain, and Emergency Medicine, University Hospital of Nîmes, Nîmes, France.

مؤلفون مشاركون: BLING III Study Investigators

المصدر: JAMA [JAMA] 2024 Aug 27; Vol. 332 (8), pp. 629-637.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Comment

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Intensive Care Units* , Meropenem*/administration & dosage , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Sepsis*/drug therapy , Sepsis*/mortality , beta Lactam Antibiotics*/administration & dosage, Aged ; Female ; Humans ; Male ; Middle Aged ; Critical Illness ; Drug Administration Schedule ; Infusions, Intravenous ; Adult ; Hospital Mortality

المؤلفون: Taggart M; Allergy, Asthma and Clinical Immunology, The Alfred, Melbourne, Victoria, Australia., Hew M; Allergy, Asthma and Clinical Immunology, The Alfred, Melbourne, Victoria, Australia., Zubrinich C; Allergy, Asthma and Clinical Immunology, The Alfred, Melbourne, Victoria, Australia.

المصدر: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2024 Jul; Vol. 54 (7), pp. 521-523. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Letter

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8906443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2222 (Electronic) Linking ISSN: 09547894 NLM ISO Abbreviation: Clin Exp Allergy Subsets: MEDLINE

مواضيع طبية MeSH: Drug Hypersensitivity*/diagnosis , Drug Hypersensitivity*/immunology , Drug Hypersensitivity*/etiology , Piperacillin, Tazobactam Drug Combination*/adverse effects , beta-Lactams*/adverse effects , beta-Lactams*/immunology , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/immunology, Humans ; Male ; Female ; Middle Aged ; Aged ; Drug Labeling ; Adult ; Piperacillin/adverse effects ; Piperacillin/immunology

المؤلفون: Meier N; Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Munch MW; Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Granholm A; Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Perner A; Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Hertz FB; Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark., Venkatesh B; Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia., Hammond NE; Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia., Li Q; Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia., De Bus L; Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., De Waele J; Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Kauzonas E; Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, Sweden., Sjövall F; Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, Sweden., Møller MH; Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Helleberg M; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

المصدر: Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2024 Jul; Vol. 68 (6), pp. 821-829. Date of Electronic Publication: 2024 Mar 28.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0370270 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-6576 (Electronic) Linking ISSN: 00015172 NLM ISO Abbreviation: Acta Anaesthesiol Scand Subsets: MEDLINE

مواضيع طبية MeSH: Piperacillin, Tazobactam Drug Combination*/therapeutic use , Carbapenems*/therapeutic use , Anti-Bacterial Agents*/therapeutic use, Humans ; Retrospective Studies ; Female ; Male ; Middle Aged ; Aged ; Cohort Studies ; Critical Care ; Intensive Care Units ; Length of Stay/statistics & numerical data ; Critical Illness

المؤلفون: Anderson K; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital, Providence, RI., Scarpaci M; Hassenfeld Child Health Innovation Institute, Brown University School of Public Health, Providence, RI., Hardy E; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital, Providence, RI; Division of Infectious Disease, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI., Li C; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital, Providence, RI 02885., Lewkowitz AK; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital, Providence, RI 02885., Rouse DJ; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital, Providence, RI 02885., Polnaszek BE; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital, Providence, RI 02885. Electronic address: brock.polnaszek@gmail.com.

المصدر: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2024 Jul; Vol. 231 (1), pp. e9-e11. Date of Electronic Publication: 2024 Feb 27.

نوع المنشور: Letter; Comparative Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0370476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6868 (Electronic) Linking ISSN: 00029378 NLM ISO Abbreviation: Am J Obstet Gynecol Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage , Ampicillin*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Propensity Score* , Gentamicins*/therapeutic use, Humans ; Female ; Pregnancy ; Chorioamnionitis/drug therapy ; Adult ; Retrospective Studies

المؤلفون: Hardy M; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia., Harris PNA; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; Central Microbiology Laboratory, Pathology Queensland, Brisbane, Queensland, Australia., Paterson DL; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.; Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Chatfield MD; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia., Mo Y; ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Division of Infectious Diseases, University Medicine Cluster, National University Hospital, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

مؤلفون مشاركون: MERINO Trial Investigators

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1482-1489.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Meropenem*/therapeutic use , Meropenem*/pharmacology , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/pharmacology , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology , Klebsiella pneumoniae*/drug effects , Piperacillin*/therapeutic use , Piperacillin*/pharmacology , Klebsiella Infections*/drug therapy , Klebsiella Infections*/mortality, Humans ; Bacteremia/drug therapy ; Bacteremia/microbiology ; Bacteremia/mortality ; Escherichia coli/drug effects ; Escherichia coli Infections/drug therapy ; Escherichia coli Infections/microbiology ; Escherichia coli Infections/mortality ; Penicillanic Acid/analogs & derivatives ; Penicillanic Acid/therapeutic use ; Penicillanic Acid/pharmacology ; Ceftriaxone/therapeutic use ; Ceftriaxone/pharmacology ; Male ; Female ; Middle Aged ; Thienamycins/therapeutic use ; Thienamycins/pharmacology ; Aged ; Treatment Outcome

المؤلفون: Mourad A; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham 27710, NC, USA., Smith AG; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Troy JD; Division of Biostatistics, Department of Biostatics & Bioinformatics, Duke University, Durham, NC, USA., Holland TL; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham 27710, NC, USA., Wrenn RH; Department of Pharmacy, Duke University Medical Center, Durham, NC, USA., Turner NA; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham 27710, NC, USA.

المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jun 03; Vol. 79 (6), pp. 1456-1461.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Ceftriaxone*/therapeutic use , Ceftriaxone*/pharmacology , Klebsiella pneumoniae*/drug effects , Klebsiella pneumoniae*/isolation & purification , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/pharmacology , Escherichia coli*/drug effects , Escherichia coli*/isolation & purification , Bacteremia*/drug therapy , Bacteremia*/microbiology , Bacteremia*/mortality , Klebsiella Infections*/drug therapy , Klebsiella Infections*/microbiology , Klebsiella Infections*/mortality , Escherichia coli Infections*/drug therapy , Escherichia coli Infections*/microbiology , Microbial Sensitivity Tests*, Humans ; Middle Aged ; Male ; Female ; Retrospective Studies ; Aged ; Treatment Outcome